Photodynamic Inactivation with Proflavine: Quantitative Comparison with Iodo-Deoxyuridine

Por Varnell, Emily D., Kaufman, Herbert E.
Publicado em 1973

Effect of 9-β-d-Arabinofuranosyladenine 5′-Monophosphate and 9-β-d-Arabinofuranosylhypoxanthine 5′-Monophosphate on Experimental Herpes Simplex Keratitis

Por Kaufman, Herbert E., Varnell, Emily D.
Publicado em 1976

Phosphonoacetic Acid in the Treatment of Experimental Ocular Herpes Simplex Infections

Por Meyer, Roger F., Varnell, Emily D., Kaufman, Herbert E.
Publicado em 1976

Effect of 9-(2-Hydroxyethoxymethyl)guanine on Herpesvirus-Induced Keratitis and Iritis in Rabbits

Por Kaufman, Herbert E., Varnell, Emily D., Centifanto, Ysolina M., Rheinstrom, Stephen D.
Publicado em 1978

A Double-Blind Placebo-Controlled Study to Evaluate Valacyclovir Alone and with Aspirin for Asymptomatic HSV-1 DNA Shedding in Human Tears and Saliva

Por Kumar, Manish, Hill, James M., Clement, Christian, Varnell, Emily D., Thompson, Hilary W., Kaufman, Herbert E.
Publicado em 2009

HSV-1 DNA in Tears and Saliva of Normal Adults

Por Kaufman, Herbert E., Azcuy, Ann M., Varnell, Emily D., Sloop, Gregory D., Thompson, Hilary W., Hill, James M.
Publicado em 2005

In Vitro Synergism of Trifluorothymidine and Ganciclovir against HSV-1

Por Hobden, Jeffery A., Kumar, Manish, Kaufman, Herbert E., Clement, Christian, Varnell, Emily D., Bhattacharjee, Partha S., Hill, James M.
Publicado em 2011

Efficacy of a Helicase-Primase Inhibitor in Animal Models of Ocular Herpes Simplex Virus Type 1 Infection

Por KAUFMAN, HERBERT E., VARNELL, EMILY D., GEBHARDT, BRYAN M., THOMPSON, HILARY W., ATWAL, EPHRAIM, RüBSAMEN-WAIGMANN, HELGA, KLEYMANN, GERALD
Publicado em 2008

Effect of High versus Low Oral Doses of Valacyclovir on Herpes Simplex Virus-1 DNA Shedding into Tears of Latently Infected Rabbits

Por Kumar, Manish, Kaufman, Herbert E., Clement, Christian, Bhattacharjee, Partha S., Huq, Tashfin S., Varnell, Emily D., Thompson, Hilary W., Hill, James M.
Publicado em 2010

Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?

Por Al-Dujaili, Lena J, Clerkin, Patrick P, Clement, Christian, McFerrin, Harris E, Bhattacharjee, Partha S, Varnell, Emily D, Kaufman, Herbert E, Hill, James M
Publicado em 2011